Americann Inc banner

Americann Inc
OTC:ACAN

Watchlist Manager
Americann Inc Logo
Americann Inc
OTC:ACAN
Watchlist
Price: 0.0001 USD Market Closed
Market Cap: $2.4k

Americann Inc
Other Liabilities

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Americann Inc
Other Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Americann Inc
OTC:ACAN
Other Liabilities
$1.7m
CAGR 3-Years
-26%
CAGR 5-Years
-17%
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
Other Liabilities
$17.3B
CAGR 3-Years
-12%
CAGR 5-Years
-10%
CAGR 10-Years
-1%
Bristol-Myers Squibb Co
NYSE:BMY
Other Liabilities
$5B
CAGR 3-Years
-9%
CAGR 5-Years
-8%
CAGR 10-Years
6%
Pfizer Inc
NYSE:PFE
Other Liabilities
$20.4B
CAGR 3-Years
-7%
CAGR 5-Years
-3%
CAGR 10-Years
2%
Merck & Co Inc
NYSE:MRK
Other Liabilities
$7.7B
CAGR 3-Years
-3%
CAGR 5-Years
-9%
CAGR 10-Years
0%
Eli Lilly and Co
NYSE:LLY
Other Liabilities
$9.8B
CAGR 3-Years
13%
CAGR 5-Years
0%
CAGR 10-Years
8%
No Stocks Found

Americann Inc
Glance View

Market Cap
2.4k USD
Industry
Pharmaceuticals

Americann, Inc. engages in the development and leasing of cannabis cultivation, processing and product manufacturing facilities. The company is headquartered in Denver, Colorado and currently employs 3 full-time employees. The company went IPO on 2013-09-10. The firm is developing product manufacturing and greenhouse cultivation facilities. Its flagship project is the Massachusetts Cannabis Center. The Massachusetts Cannabis Center (MCC) is being developed on an approximately 52-acre parcel located in Southeastern Massachusetts. Its MCC project is permitted for approximately 987,000 square feet of cannabis cultivation and processing infrastructure, which is being developed in phases to support both the existing medical cannabis and the newly emerging adult-use cannabis marketplace. Its first phase of the million square feet project, Building 1, is about 30,000 square feet. The firm through its subsidiary, AmeriCann Brands, Inc., has received two licenses from the Massachusetts Cannabis Control Commission to cultivate cannabis and provide extraction and product manufacturing support to the entire MCC project, as well as to other licensed cannabis farmers throughout regulated markets.

ACAN Intrinsic Value
Not Available

See Also

What is Americann Inc's Other Liabilities?
Other Liabilities
1.7m USD

Based on the financial report for Dec 31, 2024, Americann Inc's Other Liabilities amounts to 1.7m USD.

What is Americann Inc's Other Liabilities growth rate?
Other Liabilities CAGR 5Y
-17%

Over the last year, the Other Liabilities growth was -59%. The average annual Other Liabilities growth rates for Americann Inc have been -26% over the past three years , -17% over the past five years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett